Fairmount Funds Management Llc Aerovate Therapeutics, Inc. (AVTE) insider trading activity

AVTE Quotes by TradingView

Fairmount Funds Management LLC Transaction History

Date Transaction Value Shares Traded Form
Oct 06 2025
BUY
Grant, award, or other acquisition
$12,184,771 $9.14 p/Share
1,333,126

Also insider at

COGT
Cogent Biosciences, Inc. Healthcare
Director
VRDN
Viridian Therapeutics, Inc.\DE Healthcare
Director
MGTA
Magenta Therapeutics, Inc. Healthcare
Director
ABIO
ARCA biopharma, Inc. Healthcare
Director
GLYC
GLYCOMIMETICS INC Healthcare
Director
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
APGE
Apogee Therapeutics, Inc.
Director
ZBIO
Zenas BioPharma, Inc.
Director
FFM

Fairmount Funds Management LLC

Director
Philadelphia, PA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTE